文献速递类风湿关节炎系统性红斑狼疮其他结缔组织病

类风湿关节炎、系统性红斑狼疮和系统性硬化症患者经皮冠状动脉介入治疗结局

Percutaneous coronary intervention outcomes in patients with rheumatoid arthritis, systemic lupus erythematosus and systemic sclerosis.
PubMed 文献 · Rheumatology (Oxford) · 2020-01-01

基于美国全国住院样本(2004-2014)的回顾性分析,评估自身免疫性风湿病(AIRD)患者接受经皮冠状动脉介入治疗(PCI)的患病率及院内不良事件。AIRD占PCI住院的1.4%,其中系统性硬化症(SSc)患者所有不良结局风险显著升高,系统性红斑狼疮(SLE)患者出血风险增高,类风湿关节炎(RA)患者全因死亡率降低。

要点

  • SSc患者PCI术后任何并发症、全因死亡、出血和卒中风险均显著高于无AIRD患者。
  • SLE患者PCI术后出血风险显著增高,其他并发症与无AIRD患者无差异。
  • RA患者PCI术后全因死亡率显著降低,其他并发症与无AIRD患者无差异。

核心结论

  • 在美国全国住院队列中,SSc患者PCI术后所有不良临床结局发生率增高,SLE患者出血风险增高。
  • 此类患者的管理应涉及与风湿免疫科的多团队协作。

研究设计与样本

  • 回顾性队列研究,纳入美国全国住院样本(2004-2014)中所有PCI相关住院记录。
  • 按无AIRD、RA、SLE和SSc分为四组,使用多变量logistic回归评估院内不良事件关联。

主要发现

  • AIRD患者占PCI住院的1.4%(n=90 469)。
  • RA患病率从2004年的0.8%增至2014年的1.4%,其他AIRD亚型保持稳定。
  • SSc患者任何并发症aOR 1.13(95%CI 1.01, 1.26),全因死亡aOR 1.32(1.03, 1.71),出血aOR 1.50(1.30, 1.74),卒中aOR 1.36(1.14, 1.62)。
  • SLE患者出血aOR 1.19(95%CI 1.09, 1.29),其他并发症与无AIRD组无差异。
  • RA患者全因死亡aOR 0.79(95%CI 0.70, 0.88),其他并发症与无AIRD组无差异。

临床怎么用

  • 对SSc患者行PCI应警惕并发症、死亡、出血和卒中风险增高,建议多团队管理并纳入风湿免疫科。
  • 对SLE患者行PCI应关注出血风险增高。
  • 对RA患者行PCI未观察到除全因死亡降低外的其他并发症风险增高。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Patients with autoimmune rheumatic disease (AIRD) are at an increased risk of coronary artery disease. The present study sought to examine the prevalence and outcomes of AIRD patients undergoing percutaneous coronary intervention (PCI) from a national perspective. METHODS: All PCI-related hospitalizations recorded in the US National Inpatient Sample (2004-2014) were included, stratified into four groups: no AIRD, RA, SLE and SSc. We examined the prevalence of AIRD subtypes and assessed their association with in-hospital adverse events using multivariable logistic regression [odds ratios (OR) (95% CI)]. RESULTS: Patients with AIRD represented 1.4% (n = 90 469) of PCI hospitalizations. The prevalence of RA increased from 0.8% in 2004 to 1.4% in 2014, but other AIRD subtypes remained stable. In multivariable analysis, the adjusted odds ratio (aOR) of in-hospital complications [aOR any complication 1.13 (95% CI 1.01, 1.26), all-cause mortality 1.32 (1.03, 1.71), bleeding 1.50 (1.30, 1.74), stroke 1.36 (1.14, 1.62)] were significantly higher in patients with SSc compared with those without AIRD. There was no difference in complications between the SLE and RA groups and those without AIRD, except higher odds of bleeding in SLE patients [aOR 1.19 (95% CI 1.09, 1.29)] and reduced odds of all-cause mortality in RA patients [aOR 0.79 (95% CI 0.70, 0.88)]. CONCLUSION: In a nationwide cohort of US hospitalizations, we demonstrate increased rates of all adverse clinical outcomes following PCI in people with SSc and increased bleeding in SLE. Management of such patients should involve a multiteam approach with rheumatologists.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Martinez SC, Mohamed M, Potts J, et al. Percutaneous coronary intervention outcomes in patients with rheumatoid arthritis, systemic lupus erythematosus and systemic sclerosis. Rheumatology (Oxford). 2020. PMID: 31990337. doi:10.1093/rheumatology/kez639

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。